Collaborative Research Development Grant – Microsoft AI for Health

Deadline: 27-Mar-24

The Ovarian Cancer Research Alliance (OCRA) is inviting applications for the 2025 Collaborative Research Development Grant in partnership with Microsoft AI for Health (CRDG-AI).

For this opportunity, OCRA is partnering with Microsoft AI for Health, a philanthropic program at Microsoft, which offers access to advanced Microsoft Azure cloud computing and collaboration with data science experts for nonprofits, academia, and researchers working on challenges in the area of health, including ovarian cancer. Investigators funded through this grant opportunity have access to support from Microsoft in the form of Azure computing credits, and in-kind data science support.

The purpose of this grantmaking program is to provide funds for ovarian cancer and/or related gynecologic cancers research projects using AI or machine learning that may involve several investigators within one institution or collaborations between groups in multiple institutions. Interdisciplinary collaborations are encouraged.

Funding Information

• Support of up to $300,000USD annually for three years ($900,000USD total) will be awarded to the institution(s) in which the recipients will conduct the research.
• CRDG-AI grants have an anticipated start date of January 1, 2025.

Eligibility Criteria

• The Principal Investigator (one Principal Investigator must be selected) and other investigators must have full-time faculty appointments in a school of medicine or public health or recognized non-profit scientific research facility. They should not currently be in a training program. At least one key investigator must be a physician with expertise on ovarian cancer. International collaborations are welcome.
• The selection committee will consider most favorably applications that are creative, original, that leverage AI/machine learning, and that hold the most promise in the areas of screening and early detection, etiology and prevention, molecular therapeutics, cancer biology and genetics. Submissions that focus on health services research, quality of life, and epidemiology are also encouraged. Proposed projects should focus on ovarian cancers and/or related gynecologic cancers.
• The primary review criteria will be the likelihood that the investigators can leverage this funding to establish a research team capable of performing high-impact research and competing successfully for additional funding, and leverage the resources provided through Microsoft AI for Health.
• Investigators who wish to apply for the Collaborative Research Development Grant that do not have an AI focus or do not wish to partner with Microsoft AI for Health should apply though the other Collaborative Research Development Grant application, which is also available on SmartSimple.
• International applicants are welcome to apply.

For more information, visit OCRA.